GSI TECHNOLOGY INC
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Alex Karp Grouped Palantir With These 3 Unstoppable Stocks as the Only True Artificial Intelligence (AI) Infrastructure Winners
Palantir CEO Alex Karp recently placed his company alongside Nvidia, Micron, and SK Hynix as the biggest beneficiaries of rising investment in artificial intelligence (AI) infrastructure.
The Great Rotation Is Here. Why Money Is Fleeing Chips for Old Favorites.
U.S. stocks remain deep in the throes of a major rotation heading into the teeth of the second-quarter earnings season, and the traditional August lull that follows, as investors take money from highflying tech sector and spread that cash across a host of old-economy bets. What’s happening alongside that “great rotation,” however, is also interesting, and likely keeping stocks afloat amid the broader tech declines.
IBM Says AI Spending Isn't Crowding Out Cybersecurity. These ETFs Are Gaining Momentum
IBM says enterprises are prioritizing cybersecurity alongside AI infrastructure. Cybersecurity ETFs celebrate.
Biogen Shares Rise After Positive Phase 2 Alzheimer’s Trial Results (BIIB)
Biogen Inc. (NASDAQ:BIIB) traded higher after releasing encouraging Phase 2 data for its experimental Alzheimer’s treatment, diranersen, with results showing meaningful reductions in tau pathology alongside improvements across several measures of cognitive decline.
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
Clinical outcomes: Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose showed the strongest response with slowing of clinical decline on the cognitive endpoints—42% on ADAS-Cog13 and 50% on MMSE—alongside a 26% slowing on CDR-SBBiomarker response: Diranersen is the first tau-directed therapy to demonstrate robust reductions in both CSF total tau, with mean reductions of 50–65%, and brain t
What Broadcom (AVGO)'s Extended Apple Custom Chip Deal Through 2031 Means For Shareholders
In early July 2026, Broadcom Inc. announced that it and Apple Inc. had expanded their long-running technology collaboration through 2031 with new multi-year agreements for Broadcom to develop and supply custom ASIC silicon across multiple generations of Apple products. This long-dated Apple deal, alongside Broadcom’s rapidly growing AI semiconductor business and deepening relationships with major cloud and AI customers, reinforces its role as a key infrastructure supplier to some of the...
Southern (SO) And The Valuation Case After Its Data Center Growth Story
Southern (SO) has drawn investor interest after its stock closed at $95.61, prompting closer attention to how its recent returns, earnings profile, and dividend-oriented utility model fit into broader portfolio decisions. See our latest analysis for Southern. Recent trading has been mixed for Southern, with a modest 1-day share price return of 0.46% and a 7-day share price decline of 2.42%. The year to date share price return of 9.67% sits alongside a 5-year total shareholder return of...
Daniel Newman Says Meta Isn't Replacing Nvidia or AMD With In-House AI Chips: 'It is Augmenting…'
On Thursday, a top tech analyst said Meta Platforms, Inc.’s massive AI infrastructure investment underscores its long-term ambitions, arguing the company’s custom chip strategy is designed to expand computing capacity alongside Nvidia Corp and Advanced Micro Devices, Inc. —not replace...
Is Tyson Foods (TSN) Undervalued As Earnings And Legal Risks Stay In Focus?
Tyson Foods stock reacts to class action backdrop and earnings focus Tyson Foods (TSN) is back in focus as Canadian beef price fixing class actions continue alongside peers. Analysts are paying close attention to earnings estimate revisions and expectations for the current quarter. With some competitors agreeing to nearly US$8 million in proposed settlements that require court approval, investors are watching how ongoing litigation involving Tyson Foods intersects with projections for US$1.01...
Generative Artificial Intelligence (AI) in Utilities Market Now Available, Profiles Microsoft, IBM, NVIDIA, and 21 Other Key Industry Leaders
The generative AI in utilities market presents opportunities in enhancing utility management with applications like predictive maintenance and smart grid optimization. Key growth drivers include integration with IoT, cloud platforms, and renewable energy solutions, alongside advancements in AI algorithms for efficient and sustainable resource management. Generative AI in Utilities Market Generative AI in Utilities Market Dublin, July 10, 2026 (GLOBE NEWSWIRE) -- The "Generative AI in Utilities M
Congressional Trades in $GSIT
No disclosed congressional trades found in $GSIT.
Insider Trades (Form 4)
Cholawsky Elizabeth
Key People
Cholawsky Elizabeth
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro